PB-119

DRUG2 trials

Sponsors

PegBio Co., Ltd.

Conditions

ObesityType II Diabetes

Phase 1

Clinical Trial for PB-119 in Healthy Subjects (Phase I)

CompletedNCT02084251

PegBio Co., Ltd.Type II Diabetes

Start: 2014-02-28End: 2014-11-30Updated: 2017-02-14

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects

CompletedNCT06350812

PegBio Co., Ltd.Obesity

Start: 2024-05-27End: 2024-12-16Updated: 2025-11-19

Related Papers

Safety, Tolerability and Pharmacokinetics of Single Dose Polyethylene Glycolated Exenatide Injection (PB-119) in Healthy Volunteers.

2020-06-015 citations